Plus   Neg

Südzucker Q1 EBITDA Rises; Confirms FY 2020/21 Outlook - Quick Facts

Südzucker (SUEZF.PK) reported that its first quarter group EBITDA rose to 134 million euros from 117 million euros in the prior year.

The consolidated group operating result climbed to 61 million euros from 47 million euros in the prior year.

Quarterly revenues declined to 1.669 billion euros from 1.680 billion euros in the prior year.

In the first quarter the sugar segment's revenues fell slightly to 565 million euros from 581 million euros in the prior year. The revenue decline was driven by a significantly lower sales volume. This was partly due to reduced sugar production during the 2019 campaign.

The CropEnergies segment's revenues fell to 162 million euros from 185 million euros in the first quarter.

Looking ahead for fiscal year 2020/21, Südzucker still expects consolidated group operating result to be in the range of 300 million euros - 400 million euros, and consolidated group revenues of 6.9 billion euros - 7.2 billion euros.

The company estimates that the sugar segment's operating result will range between negative 40 million euros and positive 60 million euros.

Operating result in the CropEnergies segment is anticipated to be significantly lower, and a moderate increase in results is projected in the fruit segment.

Due to the ongoing corona pandemic and related high volatility in all segments, this outlook is still affected by a very high uncertainty.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Humana Inc. (HUM) reported second quarter adjusted earnings per share of $12.56 compared to $6.05, previous year. On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $10.27, for the quarter. Analysts' estimates typically exclude special items. Second... H-E-B has issued an all-store recall for Blue Cheese Salmon Burgers citing the presence of an undeclared allergen, the U.S. Food and Drug Administration announced. The products contain wheat, a known allergen, which is not declared on the product label. Consumers with allergy or severe sensitivity to wheat may get serious or life-threatening allergic reaction if they consume these products. The U.S. Securities and Exchange Commission is investigating the circumstances around Eastman Kodak Co.'s (KODK) announcement of a $765 million government loan to make ingredients for Covid-19 drugs, the Wall Street Journal reported citing people familiar with the matter.
Follow RTT